Philip Sutera

999 citations
38 papers · 439 indexed · h-index 10
Topics
Prostate Cancer Treatment and Research (20 papers)Prostate Cancer Diagnosis and Treatment (12 papers)Radiopharmaceutical Chemistry and Applications (8 papers)

In The Last Decade

Philip Sutera

32 papers receiving 436 citations

Peers

Philip Sutera
Comparison fields: 5 of 58
  • Oncology 147
  • Pulmonary and Respiratory Medicine 133
  • Organic Chemistry 114
  • Molecular Biology 100
  • Cancer Research 66
Replace Neeraj Rastogi with:
Neeraj Rastogi India
Roberto Diaz United States
Toshimi Sato Japan
Likuan Hu China
Hui Han China
Allen Mo United States
Ningyi Ma China
Jonas Malmquist Sweden
Chongren Wang China
Philip Sutera relative to Neeraj Rastogi India Neeraj Rastogi's profile →
Citations per field
00.5×2.9×
Neeraj Rastogi · 1×
Citations per year

Countries citing papers authored by Philip Sutera

Since Specialization
Citations

This map shows the geographic impact of Philip Sutera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip Sutera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip Sutera more than expected).

Fields of papers citing papers by Philip Sutera

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip Sutera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip Sutera. The network helps show where Philip Sutera may publish in the future.

Co-authorship network of co-authors of Philip Sutera

This figure shows the co-authorship network connecting the top 25 collaborators of Philip Sutera. A scholar is included among the top collaborators of Philip Sutera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip Sutera. Philip Sutera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 5
3 0
4 2
5 0
6 1
7 4
8 0
9 6
10 1
11 0
12 2
13 1
14 8
15 12
16 9
17 34
18 9
19 33
20 36

About Philip Sutera

Philip Sutera is a scholar working on Pulmonary and Respiratory Medicine, Health Informatics and Cancer Research, having authored 38 papers that have together received 439 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (20 papers), Prostate Cancer Diagnosis and Treatment (12 papers) and Radiopharmaceutical Chemistry and Applications (8 papers). The work is most often cited by research in Otorhinolaryngology (26 citations), Oncology (147 citations) and Cancer Research (66 citations). Philip Sutera has collaborated with scholars based in United States, Türkiye and Belgium. Frequent co-authors include Rudi Fasan, Joshua N. Kolev, Ritesh Singh, Dwight E. Heron, Steven A. Burton, Daniel R. Premkumar, Ian F. Pollack, Hong Wang, Mark E. Bernard and Ronny Kalash. Their work appears in journals such as Journal of Clinical Oncology, ACS Catalysis and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026